Braintree, Buyers Settle Generic MiraLax Suit For $17M
By Zach Winnick · January 20, 2012, 7:16 PM EST
Drug buyer plaintiffs in a putative antitrust class action accusing Braintree Laboratories Inc. of initiating baseless patent litigation to block a generic version of the laxative MiraLax asked a Delaware federal...
To view the full article, register now.